Capecitabine plus bevacizumab versus capecitabine in maintenance treatment for untreated characterised KRAS exon 2 wild-type metastatic colorectal cancer: a retrospective analysis in Chinese postmenopausal women

BACKGROUND: Capecitabine plus bevacizumab (CAP-B) maintenance treatment after 6 cycles of capecitabine, oxaliplatin, and bevacizumab (CAPOXB) has demonstrated clinical activity and failure to compromise quality of life in patients with metastatic colorectal cancer (MCC) in a previous phase 3 CAIRO3...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Gastroenterol
Main Authors: Su, Jinsong, Lai, Jiajie, Yang, Ruikun, Xu, Bo, Zhu, Ying, Zhao, Mingdong, Yang, Chen, Liang, Guanzhao
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6346504/
https://ncbi.nlm.nih.gov/pubmed/30683047
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-018-0916-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados